Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro

Oncology Letters

Volumn 11, Issue 5, 2016, Pages 3451-3456

  Wang, Yusheng ^a   Sun, Le ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Latent membrane protein 1; MicroRNA 155; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MICRORNA 155;

ARTICLE; CELL COUNTING; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY ASSAY; COLONY FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; NASOPHARYNX CARCINOMA; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 84976902566     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4400     Document Type: Article

References (25)

1. Guo X, O'Brien SJ, Zeng Y, Nelson GW and Winkler CA: GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev 17: 1760-1763, 2008.
2. Wolf H, zur Hausen H and Becker V: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 244: 245-247, 1973.
3. Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, Tao Y and Cao Y: Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res 32: 90, 2013.
4. Zhao Y, Wang Y, Zeng S and Hu X: LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: Evidence from a meta-analysis. J Clin Pathol 65: 41-45, 2012.
5. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Niu Q, Qian M, Liu G, Yang F and Teng Y: A genome-wide identification and characterization of microRNAs and their targets in ‘Suli’ pear (Pyrus pyrifolia white pear group). Planta (Sep) 8, 2013 (Epub ahead of print).
7. Wang HY, Li YY, Fu S, Wang XP, Huang MY, Zhang X, Shao Q, Deng L, Zeng MS, Zeng YX and Shao JY: MicroRNA-30a promotes invasiveness and metastasis in vitro and in vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients. Exp Biol Med (Maywood) 239: 891-898, 2014.
8. Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, et al: miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis 35: 554-563, 2014.
9. Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 299: 29-36, 2010.
10. Zhu X, Wang Y, Sun Y, Zheng J and Zhu D: MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration. Eur Arch Otorhinolaryngol 271: 1939-1945, 2014.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real time quantitative PCR and the 2(Delta Delta C(T)) Method. Methods 25: 402 408, 2001.
12. Freimoser FM, Jakob CA, Aebi M and Tuor U: The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities. Appl Environ Microbiol 65: 3727-3729, 1999.
13. Tang JM, Ma XM, Hou YL, Dai LY, Cao HB, Ye M and Bai YR: Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas. J Radiat Res 55: 794-802, 2014.
14. Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX and Zhao C: Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 48: 3422-3428, 2012.
15. Kaneda A, Matsusaka K, Aburatani H and Fukayama M: Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 72: 3445-3450, 2012.
16. Murata T, Sato Y and Kimura H: Modes of infection and oncogenesis by the Epstein-Barr virus. Rev Med Virol 24: 242-253, 2014.
17. Dawson CW, Tramountanis G, Eliopoulos AG and Young LS: Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278: 3694-3704, 2003.
18. Zhao Y, Pang TY, Wang Y, Wang S, Kang HX, Ding WB, Yong WW, Bie YH, Cheng XG, Zeng C, et al: LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma. FEBS J 281: 3004-3018, 2014.
19. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 34: 415-425, 2013.
20. Yu H, Lu J, Zuo L, Yan Q, Yu Z, Li X, Huang J, Zhao L, Tang H, Luo Z, et al: Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: A contribution to increased tumor incidence in epithelial cells. J Virol 86: 3088-3099, 2012.
21. O'Connell RM, Rao DS and Baltimore D: MicroRNA regulation of inflammatory responses. Annu Rev Immunol 30: 295-312, 2012.
22. Chen Z, Ma T, Huang C, Hu T and Li J: The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol 229: 545-550, 2014.
23. Sun S, Sun P, Wang C and Sun T: Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells. Oncol Rep 32: 951-956, 2014.
24. Mattiske S, Suetani RJ, Neilsen PM and Callen DF: The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomarkers Prev 21: 1236-1243, 2012.
25. Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM and Slack FJ: Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 109: E1695-E1704, 2012.